ATE308612T1 - Als impfstoff verwendbares attenuiertes influenzavirus - Google Patents

Als impfstoff verwendbares attenuiertes influenzavirus

Info

Publication number
ATE308612T1
ATE308612T1 AT00951687T AT00951687T ATE308612T1 AT E308612 T1 ATE308612 T1 AT E308612T1 AT 00951687 T AT00951687 T AT 00951687T AT 00951687 T AT00951687 T AT 00951687T AT E308612 T1 ATE308612 T1 AT E308612T1
Authority
AT
Austria
Prior art keywords
vaccine
virus
influenza virus
poly
usable
Prior art date
Application number
AT00951687T
Other languages
English (en)
Inventor
George Gow Brownlee
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9917981.4A external-priority patent/GB9917981D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE308612T1 publication Critical patent/ATE308612T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00951687T 1999-07-30 2000-07-28 Als impfstoff verwendbares attenuiertes influenzavirus ATE308612T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14614599P 1999-07-30 1999-07-30
GBGB9917981.4A GB9917981D0 (en) 1999-07-30 1999-07-30 Viral vaccine
PCT/GB2000/002933 WO2001009291A1 (en) 1999-07-30 2000-07-28 Attenuated influenza virus useful as vaccine

Publications (1)

Publication Number Publication Date
ATE308612T1 true ATE308612T1 (de) 2005-11-15

Family

ID=26315811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951687T ATE308612T1 (de) 1999-07-30 2000-07-28 Als impfstoff verwendbares attenuiertes influenzavirus

Country Status (9)

Country Link
EP (1) EP1200563B1 (de)
JP (1) JP2003508086A (de)
CN (1) CN1451038A (de)
AT (1) ATE308612T1 (de)
AU (1) AU6454700A (de)
CA (1) CA2380514A1 (de)
DE (1) DE60023708D1 (de)
MX (1) MXPA02001009A (de)
WO (1) WO2001009291A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080292658A1 (en) * 2004-11-11 2008-11-27 Emmie De Wit Defective Influenza Virus Particles
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN117587038A (zh) * 2005-10-19 2024-02-23 佛罗里达大学研究基金公司 能够感染犬科动物的流感病毒及其用途
GB2437799B (en) * 2006-05-24 2008-08-13 Univ Warwick Defective interfering virus
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems

Also Published As

Publication number Publication date
WO2001009291A1 (en) 2001-02-08
JP2003508086A (ja) 2003-03-04
MXPA02001009A (es) 2002-10-31
CA2380514A1 (en) 2001-02-08
AU6454700A (en) 2001-02-19
DE60023708D1 (de) 2005-12-08
EP1200563B1 (de) 2005-11-02
CN1451038A (zh) 2003-10-22
EP1200563A1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
Whisnant et al. Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus
Goldring et al. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis
Suguitan Jr et al. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals
WO2003079757A3 (en) Hiv therapeutic
EA201201356A1 (ru) Композиция для лечения респираторных синцитиальных вирусов
Dowall et al. Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
DK1218545T3 (da) Fremgangsmåder til fremstilling af oligonukleotidopløsninger
DK0857211T3 (da) Stærk homolog promoter fra hamster
WO2004013280A3 (en) ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
NO990025D0 (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
DE60322880D1 (de) Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen
WO2005105829A3 (en) Caspase-2 inhibitors and their biological applications
DE60327471D1 (de) Verfahren und zusammensetzungen zur reinigung von nukleinsäure aus einer wirtszelle
BR9904449A (pt) Processo para o preparo de ácido pantotênico através de amplificação de sequências de nucleotìdeos, as quais codificam a redutase de cetopantoato
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
ATE548454T1 (de) Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
Lim et al. Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro
Haque et al. Chromatin and splicing
HUP0302593A2 (hu) Önállóan replikálódó RNS molekula hepatitis C vírusból
Nobile et al. DNA methylation, mechanisms of FMR1 inactivation and therapeutic perspectives for fragile X syndrome
HUP0301869A2 (hu) DNS-tisztítási eljárások és a tisztított DNS
ATE308612T1 (de) Als impfstoff verwendbares attenuiertes influenzavirus
DE60331758D1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
Danker et al. Developmental information but not promoter activity controls the methylation state of histone H3 lysine 4 on two photosynthetic genes in maize

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties